← All posts

Your cycle shows up in your labs

Published September 26, 2026

Two blood draws a few weeks apart can disagree for a reason no one mentions: they were taken at different points in a menstrual cycle.

For about a week, estrogen and progesterone rise and fall by several times their starting level. They do not act only on the reproductive system. They affect the liver, fat metabolism, inflammation, insulin sensitivity, and blood volume, and those changes show up in ordinary lab tests. Menstrual bleeding also affects tests more directly. It removes iron from the body, and it can contaminate urine and stool samples.

Most lab reports ignore this. Reference ranges for routine tests are almost never adjusted for cycle phase, and the requisition form rarely asks when your last period started. If you have regular periods and you are trying to read a trend, it is worth knowing which tests are affected.

First, a note on “day 21”

Advice about cycle timing often uses a textbook 28-day cycle with ovulation on day 14. Real cycles vary much more than that. An analysis of more than 600,000 cycles recorded in a fertility-tracking app found an average cycle length of 29.3 days. The follicular phase, from the first day of a period to ovulation, ranged from about 10 to 30 days. Only 24 percent of ovulations fell on cycle day 14 or 15.

Two terms come up repeatedly below:

So “day 21” is only a convenient label for “about a week after ovulation.” It describes the right time only for someone who ovulates on day 14.

Reproductive hormones: the phase is the result

For estradiol, progesterone, LH, and FSH, a number without a cycle day cannot be interpreted. A study that tracked 85 women through a full cycle found median progesterone of about 0.2 nmol/L in the follicular phase and 28.8 nmol/L in the luteal phase, a difference of more than a hundredfold. Estradiol nearly quadrupled from the follicular phase to ovulation. LH roughly tripled at its mid-cycle surge. The authors concluded that results should be interpreted against reference values for each phase, not against one range.

That is why these tests are ordered on specific days:

If your portal shows an estradiol or progesterone result flagged high or low, check which reference range the lab used. Some labs print ranges for each phase. Others print a single range that does not fit anyone.

Iron: lowest during your period

Menstrual blood loss is the main reason iron deficiency is so common in people who menstruate. Heavy menstrual bleeding in particular is a major cause of both iron deficiency and iron deficiency anemia, and it is often dismissed as normal.

The timing of the draw also matters. In a 1993 analysis of 1,712 women from NHANES II, women whose blood was drawn during their period had lower average values than women tested in the luteal phase:

The proportion of women classified as having impaired iron status was significantly higher among those tested during menses.

A 2025 analysis of 1,484 women from NHANES 2003–2006 found a similar pattern for serum iron. Average serum iron was 72.8 µg/dL during menses and 87.8 µg/dL in the early-to-mid luteal phase. The estimated prevalence of iron deficiency anemia was 7.5 percent during menses and 3.7 percent in the late luteal phase. In that dataset, ferritin changed less than serum iron and transferrin saturation, and some other studies have also found ferritin fairly stable across the cycle.

In practice, serum iron and transferrin saturation are the iron measures most affected by cycle timing. A single low value drawn during a period is worth repeating at another point in the cycle before drawing conclusions. A persistently low ferritin is more reliable. If it stays low, ask about how heavy your periods are. That may matter more than your diet.

Cholesterol: highest in the follicular phase

The largest study of this question is the BioCycle Study, funded by the NIH. It followed 259 women through up to two cycles and drew blood up to eight times per cycle, with visits timed to ovulation using fertility monitors. Total and LDL cholesterol were highest in the follicular phase and fell during the luteal phase. HDL peaked around ovulation. Higher estradiol was associated with higher HDL and lower LDL and triglycerides.

A review of this work in Epidemiologic Reviews put the typical within-cycle swing at roughly 7 to 17 percent for LDL and 4 to 10 percent for total cholesterol. That is small for any one person. It is large enough, though, that a person near a treatment cutoff could fall on either side of it depending on the week of the draw. The authors suggest measuring at the same point in the cycle each time.

CRP: highest during your period

High-sensitivity CRP is used to estimate cardiovascular risk, and levels above 3 mg/L are considered elevated. Also in BioCycle, CRP was highest during menses and lowest at ovulation. Levels were about 1.6 times higher during menses than at ovulation. More women had CRP above 3 mg/L during menses than at other points in the cycle: 12.3 percent vs. 7.4 percent. Higher estradiol was associated with lower CRP.

If an hs-CRP result is borderline and the blood was drawn during your period, a repeat at a different point in the cycle is reasonable before treating it as your baseline.

Insulin and glucose: higher in the luteal phase

Progesterone reduces insulin sensitivity. In BioCycle, insulin resistance measured by HOMA-IR rose by about 18 percent from the mid-follicular phase to the early luteal phase. For most people without diabetes, this does not change a fasting glucose or HbA1c enough to matter clinically. It can matter for fasting insulin or HOMA-IR, which some wellness panels now include.

For people with type 1 diabetes, the effect is easier to see. A 2026 study in Diabetes Care followed 77 people on automated insulin delivery across 380 cycles. It found insulin sensitivity was highest in the early follicular phase and lowest in the mid-luteal phase. Total daily insulin dose rose accordingly, time in range fell, and most participants followed the pattern individually as well as on average. If your CGM data get worse at the same point every month, this may be why.

Urine tests: blood from a period can cause a false positive

This is the most direct effect and the easiest to prevent. Menstrual blood in a urine sample can make a dipstick read positive for blood. The American Urological Association’s teaching material on hematuria lists free hemoglobin from menstrual blood as a cause of false-positive dipstick readings. The AUA’s microhematuria guideline advises repeating the urinalysis once a gynecologic cause has resolved.

Blood also carries protein, so a urine albumin or protein test collected during a period can read falsely high. MedlinePlus advises telling your provider if you are on your period before a urine albumin-to-creatinine ratio test.

If a routine urinalysis is due, schedule it for a week when you are not bleeding. If you cannot avoid it, tell the collection staff, since a result they know may be contaminated can be interpreted differently or repeated.

Stool tests and Pap tests

The same issue applies to tests that look for hidden blood or examine cervical cells:

If you use hormonal contraception

Combined hormonal contraceptives suppress the natural cycle, so the phase effects above mostly disappear. The estrogen in them has its own effects on some tests. It raises the liver’s production of binding proteins, including sex hormone-binding globulin, thyroxine-binding globulin, and cortisol-binding globulin. In a randomized trial comparing two combined pills, total cortisol and binding globulins rose while TSH and free T4 did not change meaningfully.

The main consequence is that total T4, total T3, and total cortisol can look high on the pill while thyroid and adrenal function are normal. Free hormone levels and TSH are more reliable. Estrogen-containing pills can also raise triglycerides, and the size of the increase depends on the estrogen used. In a study of an estetrol-based pill, triglycerides rose about 24 percent, compared with about 66 percent for a comparable ethinylestradiol pill.

If you start or stop the pill, expect some of these values to change for that reason alone. Mark the date the same way you would for any other medication.

What to do about it

You do not need to schedule every blood draw around your cycle. Most routine tests are affected only modestly. A few habits make your results much easier to interpret:

  1. Write down the first day of your last period at every blood draw. It takes seconds, and afterward you can always tell which phase a result came from.
  2. For tests you repeat to follow a trend (lipids, iron, hs-CRP), try to draw at about the same point in the cycle each time. The early-to-mid follicular phase, shortly after your period ends, is a practical default for most tests.
  3. Avoid urine, stool, and Pap tests during your period when you can.
  4. Ask which phase a hormone test assumes, and whether your own cycle length changes the day it should be drawn.
  5. Treat one surprising result as a reason to repeat the test, especially if it was drawn during your period.
  6. Record hormonal contraception starts and stops, just like any other medication.

Why we build this

A lab’s reference range cannot account for your cycle, but your own history can. With enough results, you can compare each value with others drawn at a similar point in your cycle and see which differences are real.

In HealthViewer, log your periods in Cycle, including past ones if you remember them. Every result drawn while you were tracking then shows its cycle day and estimated phase, and tests that vary with the cycle carry a short note about how. Click Cycle in Trends to shade period days behind each chart. Add a pause for pregnancy or hormonal contraception, and record the contraception in Medications so its start and stop dates appear on the same charts. The data stay in an encrypted file on your own device.


This post is general information, not medical advice. Cycle effects differ between people, and conditions such as PCOS, thyroid disease, perimenopause, and pregnancy change the picture. Talk to your clinician before acting on any single result.